Fetal Skin Cell Protein Compositions for Scarless Healing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies do not provide a mechanism for scarless healing, and existing treatments for skin conditions often rely on single active agents, which may not effectively address the complex immunologic and inflammatory pathways involved in inflammatory, neurogenic, and neuroinflammatory skin conditions.
Innovation Solution
A composition containing fetal skin cell proteins obtained from fetal skin cells through induced cell lysis, which are incorporated into a carrier for topical administration, providing a balanced orchestration of skin inflammation and regeneration, including cytokines, enzymes, and structural proteins to promote scarless healing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If single active agents are used for treating skin conditions, then treatment simplicity is maintained, but effectiveness in addressing complex immunologic and inflammatory pathways is insufficient
Solution Approach 1:
The patent combines multiple fetal skin cell proteins (including cytokines, growth factors, and extracellular matrix components) into a single composition that works synergistically to address complex skin conditions through coordinated immunologic and inflammatory pathway modulation
Solution Approach 2:
The invention uses a composite formulation containing multiple different fetal skin cell proteins extracted from fetal skin cells, creating a multifaceted therapeutic agent that targets multiple pathological mechanisms simultaneously
2Reliability
If fetal skin cell proteins are used to promote scarless healing, then wound repair quality is improved, but the complexity of obtaining and processing fetal skin cells increases
Solution Approach 1:
The patent collects and processes fetal skin cells during the perinatal period when they naturally exhibit scarless healing properties, extracting proteins at this optimal time before the cells lose their unique characteristics, thereby preserving their therapeutic potential
Solution Approach 2:
The invention extracts specific proteins from fetal skin cells through controlled cell lysis and purification processes, isolating the active scarless-healing components while discarding unnecessary cellular material
Data Source
AI summary
The present invention provides methods and compositions designed for treating a subject suffering from skin conditions, disorders or diseases. The compositions include fetal skin cell proteins obtained from fetal skin cells after induced cell lysis.